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Abstract
Background: Tongue squamous cell carcinoma is one of the prominent cancers in the oral cavity. Molecular investigations based
on interaction analysis can be promising towards providing a better resolution of malignant neoplasms. Here, the protein-protein
interaction network of tongue cancer is studied.
Methods: The protein-protein interaction network was constructed by the application of Cytoscape 3.5.1 and the related algorithms.
Centrality analysis via the degree, betweenness, and closeness centralities was conducted.
Results: The result indicated that there are seven chief proteins in the network foundation. Moreover, enrichment evaluation sug-
gested two associated biological processes including Response to UV-A, Response to interlukin-7, cellular response to alcohol, and
catenin import into nucleus process using CluePedia.
Conclusions: It can be concluded that the identified central panel proteins and their related biological processes can shed light on
the neoplasm mechanisms and are worth pursuing for clinical approaches.
Keywords: Tongue Squamous Cell Carcinoma, Protein-Protein Interaction Network Analysis, Gene Ontology, Biological Process,
Topological Analysis
1. Background
Tongue Squamous Cell Carcinoma (TSCS) is one of the
important aggressive head and neck cancers whose man-
agement and treatment is challenging (1). This tumor is
frequent in people with chronic smoking, drinking, and
betel squid chewing habits. The clinical symptoms are
mostly apparent at the late stage of the disease when the
chance of mortality is high; in addition to this, there is
a high possibility of recurrence of malignancy after the
treatment interventions (2, 3). Despite improvement of
disease research and management, these measures are
still inadequate due to the disease complexity (3). So, a
need for reaching a more sophisticated method of disease
management is needed. In this light, biomarker investi-
gation is helpful to better understand the nature of the
disease and consequently to achieve novel prognosis and
treatment approaches. Transcriptomic, microRNA profil-
ing and proteomics are the most recent high-throughput
evaluations of TSCS (2, 4, 5). Specifically, proteins as the
fundamental acting parts of living organisms have a def-
inite place in molecular research. Many abnormal phe-
notypes and disease onset and developments are linked
to the proteins’ behaviors (6). Furthermore, interpreta-
tion of interaction of these fundamental elements can pro-
vide additional knowledge about the whole system mal-
functions. In the other words, organism functions are fa-
cilitated through complex molecular interactions (7). In a
protein-protein interaction network, there are complex in-
teractions between proteins where any alteration in this
level can promote an abnormal phenotype such as a dis-
ease condition (8). In fact, any small modifications in these
agents may affect the molecular interaction arrangements
and biological processes that are known as key for normal
functions (9). In this regard, network analysis is a useful
tool to introduce the crucial proteins as essential elements
of the network among numerous proteins. This is possible
via topological evaluation of the each protein (10). Degree,
betweenness, and closeness are used frequently as the im-
portant centrality parameters (11). Degree is the number of
the edges that are ended to a node (protein) and the node
with a high value of degree is called hub (12). Betweenness
value for node T in a network including N nodes is calcu-
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lated as ratio of G phrase divided by the number of the
possible paired nodes excluding the T node (13). Where G
is sum of the ratio of the shortest paths between a paired
node, where a node acts as bridge in those divided by the
all shortest paths between these two nodes. The node char-
acterized by high value of betweenness is known as bot-
tleneck node. Closeness, the other centrality parameter of
a node T, is equal to inverse of average of shortest paths
between the node T and the other nodes (14). These high-
lighted parameters via topological analysis may play a con-
siderable role in disease mechanisms (15). Therefore, in
this study by the application of protein-protein interac-
tion network, an attempt is made to provide a preliminary
knowledge of interaction pattern and to introduce crucial
interacting biomarker panel of tongue squamous cell car-
cinoma.
2. Methods
The protein-protein interaction network was con-
structed and analyzed by Cytoscape 3.5.1 and its applica-
tions. In a way that the network query was by STRING DB V
10.5 (http://string-db.org/), Plug-in. Three different sources
are applicable through string DB including protein query,
PubMed query, and disease query (16). The latter one was
used for the network construction and a confidence score
of interaction was set to 0.4. The topological understand-
ing of the network was by the application of Network An-
alyzer, which is a well-integrated application in Cytoscape
(17). Three critical centrality parameters were focused for
the network evaluation including degree (K), betweenness
centrality, and closeness centrality. Nodes with highest val-
ues of degree and betweenness centrality are considered
as hub and bottleneck elements, respectively (10). Follow-
ing the topological analysis, the important nodes were tar-
geted for enrichment examination and action type iden-
tification via ClueGo + CluePedia Plug-ins. STRING Action
File available in the CluePedia Panel was the source for ac-
tion query. The action type analyses were activation and in-
hibition which are assigned with different colors. The sta-
tistical method for scoring the actions was kappa statistics
which is customizable from 0 to 1 and it can be shown as
thick and thin lines. Here, it is set to 0.5 (medium) cut off
for any kinds of actions. Gene ontology analysis of the es-
sential elements was based on biological process identifi-
cation. Clusters of terms are connected with the assigned
kappa scores in biological processes analysis. The higher
the kappa score, the higher the possibility of terms’ link-
age. The assigned statistical criteria are as below:
Kappa score = 0.4, Corrected P value < 0.05
Number of genes per term = 3, Percentage for the
queried terms = 4
Grouping level: Min = 2, Max = 8
P value correction method: Bonferroni step
down. Enrichment/depletion test: two-sided (enrich-
ment/depletion) test based on hypergeometric distribu-
tion (18, 19).
3. Results
Following the network query for 200 related proteins
in tongue squamous cell carcinoma via string DB, Cy-
toscape, a subnetwork of connected nodes was extracted
(Figure 1). Analyzing the distribution of important param-
eters of the network including degree, betweenness, and
closeness centrality is presented in Figure 2. The finding
corresponds to the scale free network. Cut offs for degree,
betweenness centrality and closeness centrality were de-
termined based on average + 2SD (20). In the mentioned
article, the applied method was only suggested for degree
value, but here we have adjusted it for other centrality val-
ues as well. By this method the suitable number of nodes
were selected. So the critical nodes were selected by de-
gree, betweenness, and closeness values above 45, 0.05,
and 0.56, respectively (Table 1). Interaction type analysis
can provide further information about the central pro-
teins’ behavior in the constructed network (Figure 3). En-
richment analysis based on biological process of the cru-
cial proteins, as it is shown in the Figure 4, can provide in-
formation related to disturbed processes and their roles
in the disease pathogenicity. The reason for choosing only
critical proteins for gene ontology analysis was to deter-
mine the more essential biological processes.
4. Discussion
Network medicine is a relatively new discipline that ap-
plies different algorithms to provide a better understand-
ing of molecular concept of different diseases including
cancer (9). Cytoscape as one of the most popular software
for network construction (see Figure 1) and characteriza-
tion is selected for the present study. With regard to the
complex structure of interacting map, more information
can be reachable through topological assessments. For
this reason, the connecting nodes were examined for the
further study by the relevant plug-ins. Node distribution
analysis (Figure 2) indicates a scale free mode of the net-
work. In scale free networks, the nodes play different roles
in the network and can be ranked as crucial and ordinary
nodes in the studied network (21). The trend in degree, be-
tweenness, and closeness centralities distribution implies
on noteworthy distance of limited numbers of proteins
from the other ones. Considering calculated cut offs for as-
sessing centrality parameters based on designed method
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Table 1. The List of Central Proteins in the Constructed Network Analyzed Based on Degree, Betweenness Centrality, and Closeness Centralitya
Row Name Description D(K) BC CC DS
1 TP53 Tumor protein p53 65 0.14 0.62 1.30
2 AKT1 V-akt murine thymoma viral oncogene homolog 1 61 0.09 0.62 0.94
3 EGFR Epidermal growth factor receptor 55 0.06 0.60 0.80
4 EGF Epidermal growth factor 53 0.06 0.58 0.70
5 CDH1 Cadherin 1, type 1, E-cadherin (epithelial) 51 0.08 0.57 1.66
6 CTNNB1 Catenin (cadherin-associated protein), beta 1, 88kDa 49 0.07 0.57 1.34
7 CCND1 Cyclin D1 45 0.05 0.56 1.02
aCut offs for degree, betweenness centrality and closeness centrality are 45, 0.05, and 0.56, respectively. The disease score is indicated as DS.
Figure 1. A, A network of tongue squamous cell carcinoma including 132 interacting and 68 isolated nodes is presented. The connected elements are highlighted in yellow
while the individuals are in different ranges of colors. B, the main connected component including 132 nod and 923 edges is illustrated.
(22), seven proteins including TP53, AKT1, EGFR, EGF, CDH1,
CTNNB1, and CCND1 were purposed as indicated in Table
1. These proteins were reviewed by literature survey all of
which were confirmed to have significant associations in
TSCS by many studies (23-28). As it will be discussed, these
proteins have been known to have noteworthy participa-
tion in many malignancies. Therefore, a panel of them may
be more promising in tongue cancer screening. The im-
portant role of TP53 in prognosis of TSCC is discussed in
details (29). However this protein is related to almost all
of the cancer types (30). Based on previous investigations,
dysregulation of AKT1 is linked to TSCC. Its role in lymph
node metastasis is highlighted. Correlation between AKT1
and reduced overall survival of the cancer patient is also re-
ported (31, 32). There is compelling evidence about involve-
ment of EGF and EGFR in numerous cancers such as col-
Int J Cancer Manag. 2018; 11(1):e62004. 3
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Figure 2. A Scale Free Network: Nodes Are Shown as Black Circles and the Red Line Indicates the Power Law. A, Degree distribution, Correlation: 0.94 and R-squared: 0.76; B,
Betweenness Centrality distribution, Correlation: 0.85 and R-squared: 0.45 and C, Closeness distribution, Correlation: 0.95 and R-squared: 0.86.
Figure 3. A Nested Pathway Network View Obtained from CluePedia, STRING Action
File YU is Shown. The green and red colors code activation and inhibition, respec-
tively. The cut off for these action scores was set to 0.5.
orectal, breast, osteosarcoma, and gastric cancers (33-35).
Increment of gene expression of EGFR in oral tongue squa-
mous cell carcinoma was reported by M. Ryott et al. (2009)
(25). The linkage of CDH1 is studied in the several cancers
including TSCC (36-38). The prominent roles of CTNNB1 in
nasopharyngeal carcinoma, tongue cancer cell growth, mi-
gration and invasion, initiation of some colon carcinomas
and melanomas and prostate cancer are reported in some
studies (28, 39-41). There is a correlation between leukemia,
primary head and neck squamous cell carcinoma includ-
ing tongue cancer, and lung cancer with CCND1 expression
(42-45).
As it is shown in the Figure 3, there is a complex
inhibitor or activator interaction between the seven key
genes. TP53 and AKT1 are activated merely by the other
genes directly or indirectly but the other genes are acti-
vated and also inhibited. Since TP53 activation can induce
apoptosis or cell-cycle arrest (46), it seems that the ele-
ments of biomarker panel are organized against cancer
progress and development. Additionally, these proteins
are in condensing interactions as indicated in Figure 3.
CDH1 and CTNNB1 have most actions in this network. In
spite of the key role of CTNNB1 in the interaction with other
genes, it does not have a direct relationship with TP53 and
AKT1. However, an investigation indicates that TP53 muta-
tion frequently is accompanied by CTNNB1 mutation (47).
In Figure 4, gene ontology properties of the recog-
nized central proteins based on biological process are il-
lustrated. Response to UV-A, response to interlukin-7, cel-
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Figure 4. Clusters of Biological Processes Related to Central Elements of the PPI Network. Different groups are coded with specific colors. Response to UV-A, Response to
interlukin-7, cellular response to alcohol, and catenin import into nucleus process are the identified significant processes with their corresponding central proteins of the
network. Kappa score = 0.4, Corrected P value < 0.05.
lular response to alcohol, and catenin import into nucleus
were assigned to our top central proteins. That is, these
processes may undergo vast modifications as the central
proteins dysregulate. The connection of these processes
with tongue cancer can be explained in a way that, among
these processes, only Response to UV-A has not yet been
addressed by any previous studies. Cellular response to
alcohol supports the fact that alcohol has some links to
this type of cancer as was previously reported about the
role of alcohol in oral cancers (48). Association of inter-
leukins with tongue squamous cell carcinoma has been
previously reported (49, 50). As mentioned earlier, Catinin
contributed to tongue cancer development and invasion;
therefore, catenin import into nucleus relation can be jus-
tified (28).
In conclusion, the introduced potential biomarker
panel and their associated biological processes in this
study can be important for more evaluation and conse-
quently for the tongue squamous cell carcinoma treat-
ment goals.
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